SCHEMBL8562263

SCHEMBL8562263

CC(OCI)O[Si](C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8674568 0.76 LMNA (0.58)
SCHEMBL12799153 0.74
SCHEMBL6660333 0.74
SCHEMBL1438923 0.73
SCHEMBL8889691 0.69
SCHEMBL10397541 0.69 DNM1 (0.33)
SCHEMBL1155737 0.67
SCHEMBL8319545 0.67
SCHEMBL13543019 0.67
SCHEMBL15053557 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0552060-B1 Imidazole derivatives having anti-HIV activity SHIONOGI & CO (JP) 1998-11-18 EP disclosed
EP-0700911-A1 Imidazole derivatives having anti-HIV activity SHIONOGI & CO., LTD. (JP) 1996-03-13 EP disclosed
US-5472965-A Useful for treatment of retrovirus infections; less toxic SHIONOGI & CO., LTD. (JP) 1995-12-05 US disclosed
US-5326780-A Acquired immunodeficiency syndrome SHIONOGI & CO., LTD. (JP) 1994-07-05 US disclosed
EP-0552060-A1 Imidazole derivatives having anti-HIV activity SHIONOGI & CO., LTD. (JP) 1993-07-21 EP disclosed